top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Antimicrobial Drug Resistance [[electronic resource] ] : Mechanisms of Drug Resistance, Volume 1 / / edited by Douglas L. Mayers, Jack D. Sobel, Marc Ouellette, Keith S. Kaye, Dror Marchaim
Antimicrobial Drug Resistance [[electronic resource] ] : Mechanisms of Drug Resistance, Volume 1 / / edited by Douglas L. Mayers, Jack D. Sobel, Marc Ouellette, Keith S. Kaye, Dror Marchaim
Edizione [2nd ed. 2017.]
Pubbl/distr/stampa Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017
Descrizione fisica 1 online resource (XXI, 773 p. 164 illus., 61 illus. in color.)
Disciplina 616.9041
Soggetto topico Drug resistance
Infectious diseases
Drug Resistance
Infectious Diseases
ISBN 3-319-46718-2
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto History of Drug-Resistant Microbes -- Evolutionary Biology of Drug Resistance -- Pharmacology of Drug Resistance -- Drug Development for Drug-Resistant Pathogens -- Genetic Mechanisms of Transfer of Drug Resistance -- Mutations as a Basis of Antimicrobial Resistance -- Altered Drug Targets -- Enzymatic Modification of Drugs -- Reduced Drug Penetration -- Active Efflux Mechanism -- Biofilms -- Beta-Lactamases -- Penicillin Binding Proteins -- Aminoglycosides -- Tetracyclines and ChloramphenicolQuinolones -- Plasmid Mediated Quinolone Resistance to Macrolides, Lincosamides, and Streptogramins -- Mechanisms of Resistance in Metronidazole -- Glycopeptide-resistance in eneterococci -- Daptomycin Resistance -- Oxazolidinones -- PolymyxinsSulfonamides and Trimethoprim -- Antimycobacterial Agents -- Amphotericin (Polyenes) -- Azoles -- Flucytosine -- Echinocandins -- Antifungal Targets, Mechanisms of Action, and Resistance in Candida albicans -- Herpes Nucleoside Drugs -- Influenza Drugs -- HIV Nucleoside Drugs -- HIV Non-Nucleoside Drugs -- HIV Protease Inhibitors -- HIV Entry Inhibitors -- HIV Integrase Inhibitors -- Hepatitis B -- Hepatitis C -- Agents for anaerobic protozoa -- Antimalarial Agents -- Agents for Leishmania -- Agents for Trypanosomes -- Agents for Toxoplasma -- Agents for Cryptosporidium -- Agents against Nematodes -- Agents against Trematodes and Cestodes -- Agents against Ectoparasites. .
Record Nr. UNINA-9910253931003321
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Antimicrobial Drug Resistance [[electronic resource] ] : Clinical and Epidemiological Aspects, Volume 2 / / edited by Douglas L. Mayers, Jack D. Sobel, Marc Ouellette, Keith S. Kaye, Dror Marchaim
Antimicrobial Drug Resistance [[electronic resource] ] : Clinical and Epidemiological Aspects, Volume 2 / / edited by Douglas L. Mayers, Jack D. Sobel, Marc Ouellette, Keith S. Kaye, Dror Marchaim
Edizione [2nd ed. 2017.]
Pubbl/distr/stampa Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017
Descrizione fisica 1 online resource (XXI, 855 p. 61 illus., 32 illus. in color.)
Disciplina 616.9041
Soggetto topico Drug resistance
Infectious diseases
Drug Resistance
Infectious Diseases
ISBN 3-319-47266-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto History of Drug-Resistant Microbes -- Evolutionary Biology of Drug Resistance -- Pharmacology of Drug Resistance -- Drug Development for Drug-Resistant Pathogens -- Genetic Mechanisms of Transfer of Drug Resistance -- Mutations as a Basis of Antimicrobial Resistance -- Altered Drug Targets -- Enzymatic Modification of Drugs -- Reduced Drug Penetration -- Active Efflux Mechanism -- Biofilms -- Beta-Lactamases -- Penicillin Binding Proteins -- Aminoglycosides -- Tetracyclines and ChloramphenicolQuinolones -- Plasmid Mediated Quinolone Resistance to Macrolides, Lincosamides, and Streptogramins -- Mechanisms of Resistance in Metronidazole -- Glycopeptide-resistance in eneterococci -- Daptomycin Resistance -- Oxazolidinones -- PolymyxinsSulfonamides and Trimethoprim -- Antimycobacterial Agents -- Amphotericin (Polyenes) -- Azoles -- Flucytosine -- Echinocandins -- Antifungal Targets, Mechanisms of Action, and Resistance in Candida albicans -- Herpes Nucleoside Drugs -- Influenza Drugs -- HIV Nucleoside Drugs -- HIV Non-Nucleoside Drugs -- HIV Protease Inhibitors -- HIV Entry Inhibitors -- HIV Integrase Inhibitors -- Hepatitis B -- Hepatitis C -- Agents for anaerobic protozoa -- Antimalarial Agents -- Agents for Leishmania -- Agents for Trypanosomes -- Agents for Toxoplasma -- Agents for Cryptosporidium -- Agents against Nematodes -- Agents against Trematodes and Cestodes -- Agents against Ectoparasites.
Record Nr. UNINA-9910253931103321
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2017
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Polymyxin Antibiotics: From Laboratory Bench to Bedside [[electronic resource] /] / edited by Jian Li, Roger L. Nation, Keith S. Kaye
Polymyxin Antibiotics: From Laboratory Bench to Bedside [[electronic resource] /] / edited by Jian Li, Roger L. Nation, Keith S. Kaye
Edizione [1st ed. 2019.]
Pubbl/distr/stampa Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019
Descrizione fisica 1 online resource (364 pages) : illustrations
Disciplina 615.329
Collana Advances in Experimental Medicine and Biology
Soggetto topico Bacteriology
Pharmacotherapy
Drug resistance
Drug Resistance
ISBN 3-030-16373-3
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Overview -- Multidrug resistant Gram-negative pathogens: the urgent need for ‘old’ polymyxins -- Discovery, antibacterial spectrum and chemistry -- Mechanisms of antibacterial activity -- Mechanisms of resistance -- Bioanalysis and stability of polymyxins -- In vitro pharmacodynamics and PK/PD in animals -- Antibacterial susceptibility breakpoints -- Labeling of parenteral products of colistin methanesulfonate -- Meta-analysis of polymyxin use in patients -- Clinical use of colistin -- Clinical use of polymyxin B -- Pharmacokinetics, pharmacodynamics, toxicodynamics and dosing recommendations -- Rational combinations with other antibiotics -- Toxicities in patients: management and mechanisms -- Antiendotoxin effect -- Discovery of novel polymyxin-like antibiotics -- Conclusion.
Record Nr. UNINA-9910349451403321
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui